Sort
50,496 grants matching “lung cancer”
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$685,757Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Proteomic Profiling of Idiopathic Pulmonary Fibrosis Progression Trajectory
$685,748Justin M Oldham · University Of Michigan At Ann Arbor · R01 · FY2025 · HL
Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions
$685,728Christopher I. Amos · Baylor College Of Medicine · U01 · FY2019 · CA
Genomic predictors of smoking and lung cancer risk
$685,521Christopher I. Amos · Baylor College Of Medicine · U19 · FY2019 · CA
Overcoming anti-PEG immunity to restore prolonged circulation and efficacy of PEGylated therapeutics
$685,484Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer
$685,403David T Wong · University Of California Los Angeles · U01 · FY2018 · CA
Telehealth based exercise intervention to improve functional capacity in survivors of childhood cancer with significantly limited exercise tolerance
$685,341Kirsten Kimberlie Ness · St. Jude Children'S Research Hospital · U01 · FY2023 · CA
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
$685,300David J Fulton · Augusta University · R01 · FY2021 · HL
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
$685,300David J Fulton · Augusta University · R01 · FY2023 · HL
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
$685,300David J Fulton · Augusta University · R01 · FY2022 · HL
MicroFlex Technology for Early Detection of Lung Disease
$685,252Dale A. Lawrence · Quest Product Development Corporation · R42 · FY2011 · HL
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$685,245Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$685,245Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Lung cancer oncogenotype-selective drug target discovery
$685,218Michael G Roth · Ut Southwestern Medical Center · U01 · FY2014 · CA
Elucidating Lung Cancer Etiology Among Asian American Female Never Smokers
$685,092Scarlett L Gomez · University Of California, San Francisco · R01 · FY2020 · MD
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
$685,021William Douglas Figg · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Urban and Reservation Implementation of All Nations Breath of Life to Improve Smoking Cessation Rates among American Indians
$684,985Christine Makosky Daley · Lehigh University · R01 · FY2022 · DA
Computational and functional discovery of isoforms driving cancer and drug resistance
$684,945Angela Norie Brooks · University Of California Santa Cruz · R01 · FY2025 · CA
Characterizing blood progenitor cells differentiated from human iPS and ES cells
$684,872Linzhao Cheng · Johns Hopkins University · RC2 · FY2010 · HL
CA: Tissue and Pathology
$684,809Massimo F Loda · Dana-Farber Cancer Inst · P50 · FY2012 · CA
TELEhealth Shared decision-making COaching for lung cancer screening in Primary care (TELESCOPE)
$684,756Anita Y Kinney · Rutgers Biomedical And Health Sciences · R01 · FY2025 · HL
Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation
$684,688Xiang Shu · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$684,659Udai S Kammula · Basic Sciences · Z01 · FY2007 · CA
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
$684,604Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
$684,604Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA